Logo image of IHRT

IHEARTMEDIA INC - CLASS A (IHRT) Stock Fundamental Analysis

NASDAQ:IHRT - US45174J5092 - Common Stock

2.15 USD
-0.11 (-4.87%)
Last: 9/10/2025, 8:00:01 PM
2.23 USD
+0.08 (+3.72%)
After Hours: 9/10/2025, 8:00:01 PM
Fundamental Rating

3

IHRT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 99 industry peers in the Media industry. Both the profitability and financial health of IHRT have multiple concerns. IHRT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

IHRT had negative earnings in the past year.
In the past year IHRT had a positive cash flow from operations.
IHRT had negative earnings in each of the past 5 years.
Each year in the past 5 years IHRT had a positive operating cash flow.
IHRT Yearly Net Income VS EBIT VS OCF VS FCFIHRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

1.2 Ratios

With a Return On Assets value of -6.96%, IHRT is not doing good in the industry: 62.63% of the companies in the same industry are doing better.
IHRT has a Return On Invested Capital (3.48%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for IHRT is significantly below the industry average of 8.87%.
The last Return On Invested Capital (3.48%) for IHRT is above the 3 year average (2.91%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.96%
ROE N/A
ROIC 3.48%
ROA(3y)-12.39%
ROA(5y)-11.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.91%
ROIC(5y)2.17%
IHRT Yearly ROA, ROE, ROICIHRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300

1.3 Margins

Looking at the Operating Margin, with a value of 5.11%, IHRT is in line with its industry, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Operating Margin of IHRT has declined.
The Gross Margin of IHRT (58.29%) is better than 68.69% of its industry peers.
In the last couple of years the Gross Margin of IHRT has declined.
Industry RankSector Rank
OM 5.11%
PM (TTM) N/A
GM 58.29%
OM growth 3Y-11.51%
OM growth 5Y-23.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.17%
GM growth 5Y-2.96%
IHRT Yearly Profit, Operating, Gross MarginsIHRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IHRT is destroying value.
The number of shares outstanding for IHRT has been increased compared to 1 year ago.
Compared to 5 years ago, IHRT has more shares outstanding
The debt/assets ratio for IHRT is higher compared to a year ago.
IHRT Yearly Shares OutstandingIHRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
IHRT Yearly Total Debt VS Total AssetsIHRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.26, we must say that IHRT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.26, IHRT is doing worse than 70.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.26
ROIC/WACC0.49
WACC7.1%
IHRT Yearly LT Debt VS Equity VS FCFIHRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

2.3 Liquidity

A Current Ratio of 1.50 indicates that IHRT should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.50, IHRT is doing good in the industry, outperforming 62.63% of the companies in the same industry.
IHRT has a Quick Ratio of 1.50. This is a normal value and indicates that IHRT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.50, IHRT is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
IHRT Yearly Current Assets VS Current LiabilitesIHRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

IHRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.57%, which is quite impressive.
IHRT shows a small growth in Revenue. In the last year, the Revenue has grown by 3.18%.
IHRT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.91% yearly.
EPS 1Y (TTM)63.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.69%
Revenue 1Y (TTM)3.18%
Revenue growth 3Y2.7%
Revenue growth 5Y0.91%
Sales Q2Q%0.49%

3.2 Future

Based on estimates for the next years, IHRT will show a very strong growth in Earnings Per Share. The EPS will grow by 27.28% on average per year.
The Revenue is expected to grow by 2.90% on average over the next years.
EPS Next Y66.74%
EPS Next 2Y43.47%
EPS Next 3Y27.28%
EPS Next 5YN/A
Revenue Next Year-2.89%
Revenue Next 2Y1.27%
Revenue Next 3Y0.77%
Revenue Next 5Y2.9%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IHRT Yearly Revenue VS EstimatesIHRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
IHRT Yearly EPS VS EstimatesIHRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IHRT. In the last year negative earnings were reported.
IHRT is valuated cheaply with a Price/Forward Earnings ratio of 5.51.
IHRT's Price/Forward Earnings ratio is rather cheap when compared to the industry. IHRT is cheaper than 88.89% of the companies in the same industry.
IHRT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.54.
Industry RankSector Rank
PE N/A
Fwd PE 5.51
IHRT Price Earnings VS Forward Price EarningsIHRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IHRT is valued a bit cheaper than 63.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.01
IHRT Per share dataIHRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as IHRT's earnings are expected to grow with 27.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.47%
EPS Next 3Y27.28%

0

5. Dividend

5.1 Amount

No dividends for IHRT!.
Industry RankSector Rank
Dividend Yield N/A

IHEARTMEDIA INC - CLASS A

NASDAQ:IHRT (9/10/2025, 8:00:01 PM)

After market: 2.23 +0.08 (+3.72%)

2.15

-0.11 (-4.87%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners87.32%
Inst Owner Change-0.12%
Ins Owners7.81%
Ins Owner Change3.59%
Market Cap322.80M
Analysts46.67
Price Target1.61 (-25.12%)
Short Float %5.5%
Short Ratio8.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-171.26%
Min EPS beat(2)-248.25%
Max EPS beat(2)-94.28%
EPS beat(4)0
Avg EPS beat(4)-385.76%
Min EPS beat(4)-1158.82%
Max EPS beat(4)-41.71%
EPS beat(8)1
Avg EPS beat(8)-434.83%
EPS beat(12)2
Avg EPS beat(12)-636.19%
EPS beat(16)4
Avg EPS beat(16)-475.86%
Revenue beat(2)2
Avg Revenue beat(2)0.41%
Min Revenue beat(2)0.33%
Max Revenue beat(2)0.5%
Revenue beat(4)2
Avg Revenue beat(4)-1.6%
Min Revenue beat(4)-5.95%
Max Revenue beat(4)0.5%
Revenue beat(8)3
Avg Revenue beat(8)-1.2%
Revenue beat(12)3
Avg Revenue beat(12)-0.93%
Revenue beat(16)4
Avg Revenue beat(16)-0.9%
PT rev (1m)0%
PT rev (3m)10.53%
EPS NQ rev (1m)-150%
EPS NQ rev (3m)-121.43%
EPS NY rev (1m)-17.09%
EPS NY rev (3m)-17.09%
Revenue NQ rev (1m)0.49%
Revenue NQ rev (3m)-2.76%
Revenue NY rev (1m)0.73%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.51
P/S 0.08
P/FCF N/A
P/OCF 6.47
P/B N/A
P/tB N/A
EV/EBITDA 9.01
EPS(TTM)-2.43
EYN/A
EPS(NY)0.39
Fwd EY18.15%
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)0.33
OCFY15.44%
SpS25.76
BVpS-11.53
TBVpS-29.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.96%
ROE N/A
ROCE 4.41%
ROIC 3.48%
ROICexc 3.68%
ROICexgc 10.34%
OM 5.11%
PM (TTM) N/A
GM 58.29%
FCFM N/A
ROA(3y)-12.39%
ROA(5y)-11.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.91%
ROIC(5y)2.17%
ROICexc(3y)3.07%
ROICexc(5y)2.28%
ROICexgc(3y)10.11%
ROICexgc(5y)7.82%
ROCE(3y)3.68%
ROCE(5y)2.74%
ROICexcg growth 3Y-3.39%
ROICexcg growth 5Y-18.36%
ROICexc growth 3Y9.08%
ROICexc growth 5Y-9.78%
OM growth 3Y-11.51%
OM growth 5Y-23.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.17%
GM growth 5Y-2.96%
F-Score4
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 8.73
Cap/Depr 24.73%
Cap/Sales 2.45%
Interest Coverage 0.5
Cash Conversion 8.6%
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z -0.26
F-Score4
WACC7.1%
ROIC/WACC0.49
Cap/Depr(3y)27.97%
Cap/Depr(5y)28.83%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.69%
EPS Next Y66.74%
EPS Next 2Y43.47%
EPS Next 3Y27.28%
EPS Next 5YN/A
Revenue 1Y (TTM)3.18%
Revenue growth 3Y2.7%
Revenue growth 5Y0.91%
Sales Q2Q%0.49%
Revenue Next Year-2.89%
Revenue Next 2Y1.27%
Revenue Next 3Y0.77%
Revenue Next 5Y2.9%
EBIT growth 1Y56%
EBIT growth 3Y-9.12%
EBIT growth 5Y-23.22%
EBIT Next Year201.47%
EBIT Next 3Y46.24%
EBIT Next 5Y28.19%
FCF growth 1Y-134.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.15%
OCF growth 3Y-39.99%
OCF growth 5Y-30.12%